Ganglioside with nerve growth factor for the recovery of extremity function following spinal cord injury and somatosensory evoked potential.

Zhai, H-W; Gong, Z-K; Sun, J; Chen, W; Zhang, M; Zhou, J-J; Zheng, B

Zhai, H-W; Gong, Z-K; Sun, J; Chen, W; Zhang, M; Zhou, J-J; Zheng, B.

Affiliation

Zhai HW; Department of Rehabilitation Medicine, Xuzhou Central Hospital, Xuzhou, Jiangsu Province, China. zhw2625329@163.com.

Eur Rev Med Pharmacol Sci ; 19(12): 2282-6, 2015 Jun.

Article in En | MEDLINE | ID: mdl-26166655

Subject(s)

Evoked Potentials, Somatosensory/drug effects; Gangliosides/administration & dosage; Lower Extremity; Nerve Growth Factors/administration & dosage; Recovery of Function/drug effects; Spinal Cord Injuries/diagnosis; Spinal Cord Injuries/drug therapy; Adult; Animals; Drug Therapy, Combination; Female; Humans; Lower Extremity/pathology; Male; Mice; Middle Aged; Spinal Cord Injuries/physiopathology; Young Adult

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Spinal Cord Injuries / Recovery of Function / Lower Extremity / Evoked Potentials, Somatosensory / Gangliosides / Nerve Growth Factors Type of study: Clinical_trials Limits: Adult / Animals / Female / Humans / Male / Middle aged Language: En Journal: Eur Rev Med Pharmacol Sci Year: 2015 Document type: Article

Search on Google

XML

PubMed Links